Abstract
The German pharmaceutical industry dominated global drug creation from the late nineteenth century to World War I. Most of the industry's products were based on extensive scientific research. However, the research intensity of products varied across companies and intensified over time. A main contribution of this article is thus to identify different groups of firms within the industry and provide an analysis of their product portfolios before 1914. This essay embeds scientific developments in a coevolutionary framework of science, firms, and institutions and shows that the industry's research capabilities were complemented by other important factors for corporate success.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
